News

Edmond de Rothschild Investment Partners (Paris) and UFG PE (Paris), current investors in the company, have also subscribed to the current round of financing. Aelios Finance served as

The company says the Department of Health and Human Services (HHS) granted permission because it fulfilled a number of significant milestones in the contract. The income will be

The 96-well GEN III MicroPlate panel incorporates 71 carbon source and 23 chemical sensitivity assays in a pre-coated dry chemistry format. With these 94 tests, the system analyzes

The trial is designed to evaluate the safety and efficacy of Fampridine-SR in improving walking ability in people with multiple sclerosis. 240 patients were enrolled at 39 clinical

LIHPA is a consortium of four independent Long Island Hospitals which joined together to combine their purchasing strength to reduce healthcare costs on Long Island. Ron Bredow, director

The first contract awarded by the Idaho Central District Health Department for three rapidly deployable medical response systems includes customized Blu-Med deployable medical shelters, HVAC and electrical systems,

The multi-center IDE study is designed to evaluate the safety and benefit of using the Excor paediatric VAD to support paediatric patients. The FDA granted conditional approval for

Shareholders have subscribed for the issue of 20 million ordinary shares at A$0.30 per share. This Taylor Collison placement of A$6 million follows the closing of a placement

Cymbalta is a member of a class of drugs commonly referred to as serotonin and norepinephrine reuptake inhibitors. The efficacy and safety of Cymbalta for maintenance treatment of